Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Hatch Biofund Management is a life sciences venture capital firm headquartered in the Philadelphia region, established in 2023. It operates as the investment arm of the Pennsylvania Biotechnology Center (PABC), a prominent biotech incubator. The firm is dedicated to providing early-stage capital to promising life science companies, particularly those focused on developing therapeutics and vaccines for human use. Hatch Biofund's strategic location in one of the fastest-growing biotech hubs in the United States positions it well to tap into a vibrant ecosystem of innovation.
Currently, Hatch Biofund is actively involved in supporting companies at various stages of development, from pre-seed to Series C. The firm emphasizes capital efficiency and aims to ensure that its portfolio companies have access to both financial resources and industry expertise. Notable milestones include partnerships with organizations such as Brandywine Realty Trust, which enhances the infrastructure available to portfolio companies, and collaborations with leading research institutions.
Hatch Biofund exclusively invests in private companies innovating in the fields of therapeutics and vaccines. The firm is particularly interested in capital-efficient projects that demonstrate a clear understanding of disease biology and development pathways, promising significant societal value. Investment stages range from pre-seed to Series C, with a specific focus on seed and Series A rounds. The check size typically starts at $250,000, allowing for flexibility in supporting early-stage ventures.
The firm prioritizes projects that utilize various treatment modalities, including small molecules, cell therapy, and gene therapy. Hatch Biofund's investment thesis is deeply intertwined with its affiliation with the Pennsylvania Biotechnology Center, providing portfolio companies with access to essential lab space, incubation infrastructure, and a network of industry experts. This unique positioning enhances the firm's ability to identify and support innovative life science startups.
Hatch Biofund's portfolio includes several notable companies that are making strides in the life sciences sector:
These companies exemplify Hatch Biofund's commitment to supporting innovative therapeutic solutions that address critical health challenges.
Lorenzo Pellegrini, Ph.D. - Managing Partner. Dr. Pellegrini has extensive experience in the life sciences sector, focusing on venture capital and biotechnology investments.
Louis P. Kassa III, MPA - Founder and Advisor. Kassa brings a wealth of knowledge in management and advisory roles within the biotech industry.
Timothy M. Block, Ph.D. - Founder and Advisor. Dr. Block has a strong background in biomedical research and has led numerous successful biotech ventures.
Startups interested in pitching to Hatch Biofund should visit their website at hatchbiofund.com. It is advisable to include a comprehensive deck that outlines the business model, team qualifications, and detailed information about the technology. The firm prefers warm introductions but will consider direct applications through their website. Response times may vary, but founders should expect a thorough review process.
In December 2023, Hatch Biofund announced a new partnership with Brandywine Realty Trust, which will provide portfolio companies with access to life sciences real estate infrastructure. This partnership aims to enhance the support available to startups within the Hatch Biofund portfolio.
Additionally, Hatch Biofund has been actively engaging with the life sciences community, leveraging its connections to the Pennsylvania Biotechnology Center to provide industry expertise and infrastructure support to its portfolio companies. The firm continues to seek innovative life science startups for investment.
What are Hatch Biofund's investment criteria?
Hatch Biofund invests in private companies developing therapeutics and vaccines for human use. The firm focuses on capital-efficient projects with a clear understanding of disease biology and development pathways.
How can startups apply or pitch to Hatch Biofund?
Startups can pitch to Hatch Biofund through their website at hatchbiofund.com. It is recommended to include a detailed business plan and information on the team and technology.
What makes Hatch Biofund different from other venture capital firms?
Hatch Biofund is uniquely positioned as the investment arm of the Pennsylvania Biotechnology Center, providing not only capital but also access to lab space, incubation infrastructure, and deep industry expertise.
What is the geographic scope of Hatch Biofund's investments?
The firm primarily invests in North America, focusing on the Philadelphia region, which is known for its growing biotech ecosystem.
What is the typical check size for investments?
Hatch Biofund typically invests starting at $250,000, with flexibility depending on the stage and needs of the portfolio company.
What kind of post-investment involvement does Hatch Biofund have?
Hatch Biofund actively engages with its portfolio companies, providing access to resources, mentorship, and industry connections to support their growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.